Table 1. Initial diagnosis of MPNs in... | American Society of Hematology

Table 1.

Initial diagnosis of MPNs in the analyzed patients

	All MPNs	ET	ET, corrected*	PV	PMF
No. of patients, n (%)	7454	4390 (58.9)	4307 (57.9)	2470 (33.1)	594 (8.0)
Age, y
Median (range)	60 (11-106)	61 (13-106)	61(13-106)	58 (11-100)	63 (21-89)
Category, n
0-9	0	0	0	0	0
10-19	98	75	75	23	0
20-29	254	167	165	81	6
30-39	573	355	352	189	29
40-49	1087	615	607	400	72
50-59	1641	888	867	631	122
60-69	1664	907	888	590	167
70-79	1627	1013	996	447	167
≥80	510	370	357	109	31
Sex, n
Male	3942	1944	1912	1633	365
Female	3512	2446	2395	837	229
Year, n
2008	750	462	448	212	76
2009	780	459	443	232	89
2010	705	409	397	243	53
2011	751	453	444	259	39
2012	813	499	491	267	47
2013	858	503	496	297	58
2014	896	508	498	319	69
2015	967	575	569	307	85
2016	934	522	521	334	78
Follow-up period, median (range), mo	45.63 (6.02-114.61)	46.74 (6.02-114.61)	46.38 (6.02-114.61)	47.40 (6.02-113.68)	31.78 (6.02-113.78)

	All MPNs	ET	ET, corrected*	PV	PMF
No. of patients, n (%)	7454	4390 (58.9)	4307 (57.9)	2470 (33.1)	594 (8.0)
Age, y
Median (range)	60 (11-106)	61 (13-106)	61(13-106)	58 (11-100)	63 (21-89)
Category, n
0-9	0	0	0	0	0
10-19	98	75	75	23	0
20-29	254	167	165	81	6
30-39	573	355	352	189	29
40-49	1087	615	607	400	72
50-59	1641	888	867	631	122
60-69	1664	907	888	590	167
70-79	1627	1013	996	447	167
≥80	510	370	357	109	31
Sex, n
Male	3942	1944	1912	1633	365
Female	3512	2446	2395	837	229
Year, n
2008	750	462	448	212	76
2009	780	459	443	232	89
2010	705	409	397	243	53
2011	751	453	444	259	39
2012	813	499	491	267	47
2013	858	503	496	297	58
2014	896	508	498	319	69
2015	967	575	569	307	85
2016	934	522	521	334	78
Follow-up period, median (range), mo	45.63 (6.02-114.61)	46.74 (6.02-114.61)	46.38 (6.02-114.61)	47.40 (6.02-113.68)	31.78 (6.02-113.78)

CI, confidence interval.

After excluding 83 patients whose initial diagnosis was ET, but was changed to PV during follow-up.